Loading…
Improvement of defective sarcoplasmic reticulum Ca2+ transport in diabetic heart of transgenic rats expressing the human kallikrein‐1 gene
The bradykinin‐forming enzyme kallikrein‐1 is expressed in the heart. To examine whether contractile performance and sarcoplasmic reticulum Ca2+ transport of the diabetic heart can be rescued by targeting the kallikrein‐kinin system, we studied left ventricular function and sarcoplasmic reticular Ca...
Saved in:
Published in: | The FASEB journal 2004-12, Vol.18 (15), p.1967-1969 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The bradykinin‐forming enzyme kallikrein‐1 is expressed in the heart. To examine whether contractile performance and sarcoplasmic reticulum Ca2+ transport of the diabetic heart can be rescued by targeting the kallikrein‐kinin system, we studied left ventricular function and sarcoplasmic reticular Ca2+ uptake after induction of streptozotocin‐induced diabetes mellitus in transgenic rats expressing the human tissue kallikrein‐1 gene. Six weeks after a single injection of either streptozotocin (70 mg/kg ip) or vehicle, left ventricular performance was determined using a Millar‐Tip catheter system. The Ca2+‐transporting activity of reticulum‐derived membrane vesicles was determined in left ventricular homogenates as oxalate‐supported 45Ca2+ uptake. Western blot analysis was used to quantify the reticular Ca2+‐ATPase SERCA2a, phospholamban, and the phosphorylation status of the latter. Contractile performance and Ca2+ uptake activity were similar in nondiabetic wild‐type and transgenic rats. Severely diabetic wild‐type animals exhibited impaired left ventricular performance and decreased reticular Ca2+ uptake (‐39% vs. wild‐type rats, P |
---|---|
ISSN: | 0892-6638 1530-6860 |
DOI: | 10.1096/fj.04-1614fje |